Advanced search
Publication Cover
Leukemia & Lymphoma Volume 62, 2021 - Issue 7
Submit an article Journal homepage
214
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Searching for germline mutations in the RUNX1 gene among Polish patients with acute myeloid leukemia

Aneta Bąka Department of Clinical Genetics, Collegium Medicum, Bydgoszcz, Nicolaus Copernicus University, Toruń, PolandCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-8879-2521View further author information
ORCID Icon,
Katarzyna Skonieczkaa Department of Clinical Genetics, Collegium Medicum, Bydgoszcz, Nicolaus Copernicus University, Toruń, PolandView further author information
,
Anna Jaśkowiecb Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Medical University, Wrocław, PolandView further author information
,
Anna Junkiert-Czarneckaa Department of Clinical Genetics, Collegium Medicum, Bydgoszcz, Nicolaus Copernicus University, Toruń, PolandView further author information
,
Marta Heisea Department of Clinical Genetics, Collegium Medicum, Bydgoszcz, Nicolaus Copernicus University, Toruń, PolandView further author information
,
Maria Pilarska-Deltowa Department of Clinical Genetics, Collegium Medicum, Bydgoszcz, Nicolaus Copernicus University, Toruń, PolandView further author information
,
Stanisław Potoczekb Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Medical University, Wrocław, PolandView further author information
,
Maria Czyżewskac Department of Hematology, Municipal Hospital, Toruń, PolandView further author information
&
Olga Hausa Department of Clinical Genetics, Collegium Medicum, Bydgoszcz, Nicolaus Copernicus University, Toruń, PolandView further author information
 show all
Pages 1749-1755 | Received 21 Jul 2020, Accepted 16 Jan 2021, Published online: 10 Feb 2021

References

  • Haferlach T, Nagata Y, Grossmann V, et al. Landscape of genetic lesions in 944 patients with myelodysplastic syndromes. Leukemia. 2014;28(2):241–247.
  • Malcovati L, Papaemmanuil E, Ambaglio I, et al. Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia. Blood. 2014;124(9):1513–1521.
  • Sakurai M, Kunimoto H, Watanabe N, et al. Impaired hematopoietic differentiation of RUNX1-mutated induced pluripotent stem cells derived from FPD/AML patients. Leukemia. 2014;28(12):2344–2354.
  • Sood R, Kamikubo Y, Liu P. Role of RUNX1 in hematological malignancies. Blood. 2017;129(15):2070–2082.
  • Ng IK, Lee J, Ng C, et al. Preleukemic and second-hit mutational events in an acute myeloid leukemia patient with a novel germline RUNX1 mutation. Biomark Res. 2018;6:16.
  • Bluteau D, Gilles L, Hilpert M, et al. Down-regulation of the RUNX1-target gene NR4A3 contributes to hematopoiesis deregulation in familial platelet disorder/acute myelogenous leukemia. Blood. 2011;118(24):6310–6320.
  • Zhao X, Chen A, Yan X, et al. Downregulation of RUNX1/CBFβ by MLL fusion proteins enhances hematopoietic stem cell self-renewal. Blood. 2014;123(11):1729–1738.
  • Friedman AD. Cell cycle and developmental control of hematopoiesis by Runx1. J Cell Physiol. 2009;219(3):520–524.
  • Goldfarb AN. Megakaryocytic programming by a transcriptional regulatory loop: a circle connecting RUNX1, GATA-1, and P-TEFb. J Cell Biochem. 2009;107(3):377–382.
  • Wong WF, Kohu K, Chiba T, et al. Interplay of transcription factors in T-cell differentiation and function: the role of Runx. Immunology. 2011;132(2):157–164.
  • Boller S, Grosschedl R. The regulatory network of B-cell differentiation: a focused view of early B-cell factor 1 function. Immunol Rev. 2014;261(1):102–115.
  • Cai X, Gao L, Teng L, et al. Runx1 deficiency decreases ribosome biogenesis and confers stress resistance to hematopoietic stem and progenitor cells. Cell Stem Cell. 2015;17(2):165–177.
  • Chuang LSH, Ito K, Ito Y. RUNX family: regulation and diversification of roles through interacting proteins. Int J Cancer. 2013;132(6):1260–1271.
  • Connelly JP, Kwon EM, Gao Y, et al. Targeted correction of RUNX1 mutation in FPD patient-specific induced pluripotent stem cells rescues megakaryopoietic defects. Blood. 2014;124(12):1926–1930.
  • Ripperger T, Steinemann D, Gohring G, et al. A novel pedigree with heterozygous germline RUNX1 mutation causing familial MDS-related AML: can these families serve as a multistep model for leukemic transformation? Leukemia. 2009;23(7):1364–1366.
  • Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. IARC. 2017;8:129–170.
  • Goyama S, Schibler J, Gasilina A, et al. UBASH3B/Sts-1-CBL axis regulates myeloid proliferation in human preleukemia induced by AML1-ETO. Leukemia. 2016;30(3):728–739.
  • Zamecnikova A. Del(7)(p11-15) solely. Atlas Genet Cytogenet Oncol Haematol. 2018;22(7):298–302.
  • Buijs A, Poot M, van der Crabben S, et al. Elucidation of a novel pathogenomic mechanism using genome-wide long mate-pair sequencing of a congenital t(16;21) in a series of three RUNX1-mutated FPD/AML pedigrees. Leukemia. 2012;26(9):2151–2154.
  • Michaud J, Wu F, Osato M, et al. In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis. Blood. 2002;99(4):1364–1372.
  • Yokota A, Huo L, Lan F, et al. The clinical, molecular, and mechanistic basis of RUNX1 mutations identified in hematological malignancies. Mol Cells. 2020;43(2):145–152.
  • Churpek JE, Bresnick EH. Transcription factor mutations as a cause of familial myeloid neoplasms. J Clin Invest. 2019;129(2):476–488.
  • Latger-Cannard V, Philippe C, Bouquet A, et al. Haematological spectrum and genotype-phenotype correlations in nine unrelated families with RUNX1 mutations from the French network on inherited platelet disorders. Orphanet J Rare Dis. 2016;11:49.
  • Yoshimi A, Toya T, Kawazu M, et al. Recurrent CDC25C mutations drive malignant transformation in FPD/AML. Nat Commun. 2014;5:4770.
  • Antony-Debré I, Duployez N, Bucci M, et al. Somatic mutations associated with leukemic progression of familial platelet disorder with predisposition to acute myeloid leukemia. Leukemia. 2016;30(4):999–1002.
  • Stein EM. Molecularly targeted therapies for acute myeloid leukemia. Hematology Am Soc Hematol Educ Program. 2015;2015:579–583.
  • Mill CP, Fiskus W, DiNardo CD, et al. RUNX1-targeted therapy for AML expressing somatic or germline mutation in RUNX1. Blood. 2019;134(1):59–73.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.